ARCHIVES

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

This article is from The Cancer Letter archive.

Vol. 01 No. 39 | November 1, 1974

Download PDF Visit The Full Archive

Related Articles

FDA developing guidelines for oncology endpoints.

May 7, 2004

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

Greenberg: More Work Needs to be Done

November 7, 2014